| Trasylol Lawsuit & News Blog | |
Blog Home Archives Articles Category Index Trasylol - Kidney Failure & Stroke - Dialysis Centers and Stroke Resources
|
Blog Home : AG Bayer
: Article
Bayer AG can expect a slowdown in the growth in sales of its blood loss drug Trasylol, after an independent study showed that the drug was associated with health risks, board member Wolfgang Plischke said after the full-year results news conference
Bayer AG can expect a slowdown in the growth in sales of its blood loss drug Trasylol, after an independent study showed that the drug was associated with health risks, board member Wolfgang Plischke said after the full-year results news conference. An independent study showed in January that use of the drug was associated with increased risk of kidney failure, higher stroke risk and encephalopathy, a degenerative disease of the brain, in cardiac surgery.
|
Law Offices of Michael Monheit 1368 Barrowdale Road Rydal, PA 19046
Call Us Toll Free: 866-761-1385 P: 215-840-6573 E: Michael@Monheit.com
